TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds’ pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development

AIM: Thermoregulatory side effects hinder the development of transient receptor potential vanilloid‐1 (TRPV1) antagonists as new painkillers. While many antagonists cause hyperthermia, a well‐studied effect, some cause hypothermia. The mechanisms of this hypothermia are unknown and were studied here...

Descripción completa

Detalles Bibliográficos
Autores principales: Garami, A., Pakai, E., McDonald, H. A., Reilly, R. M., Gomtsyan, A., Corrigan, J. J., Pinter, E., Zhu, D. X. D., Lehto, S. G., Gavva, N. R., Kym, P. R., Romanovsky, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Metobolism and Nutritional Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032921/
https://www.ncbi.nlm.nih.gov/pubmed/29352512
http://dx.doi.org/10.1111/apha.13038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032921/
https://www.ncbi.nlm.nih.gov/pubmed/29352512
http://dx.doi.org/10.1111/apha.13038

Ejemplares similares